Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese

Journal of Neuroimmunology

Volumn 271, Issue 1-2, 2014, Pages 43-48

  Liu, Ying ^a   Yu, Jin Tai ^b,c   Zhang, Wei ^b   Zong, Yu ^b   Lu, Rui Chun ^b   Zhou, Jing ^a   Tan, Lan ^a,b,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Association study; IL23R; Interleukin 23; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 23 RECEPTOR;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; APOE GENE; ARTICLE; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENDER; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SELECTION; GENOTYPE; HAPLOTYPE; HUMAN; IL23R GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER'S DISEASE; ASSOCIATION STUDY; IL23R; INTERLEUKIN-23; POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN;

EID: 84900496339     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.03.013     Document Type: Article

References (33)

1. Abraham C., Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2009, 60:97-110.
2. Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 2010, 23:213-227.
3. Cho M.L., Kang J.W., Moon Y.M., Nam H.J., Jhun J.Y., Heo S.B., et al. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 2006, 176:5652-5661.
4. Chu H., Cao W., Chen W., Pan S., Xiao Y., Liu Y., et al. Potentially functional polymorphisms in IL-23 receptor and risk of esophageal cancer in a Chinese population. Int. J. Cancer 2012, 130:1093-1097.
5. Eikelenboom P., Veerhuis R., Scheper W., Rozemuller A.J., van Gool W.A., Hoozemans J.J. The significance of neuroinflammation in understanding Alzheimer's disease. J. Neural Transm. 2006, 113:1685-1695.
6. Favis R., Day J.P., Gerry N.P., Phelan C., Narod S., Barany F. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat. Biotechnol. 2000, 18:561-564.
7. Ferguson L.R., Han D.Y., Fraser A.G., Huebner C., Lam W.J., Morgan A.R. IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol. Res. Pract. 2010, 2010:539461.
8. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
9. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
10. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435.
11. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099.
12. Lettre G., Lange C., Hirschhorn J.N. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 2007, 31:358-362.
13. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9:356-369.
14. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006, 27:17-23.
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
16. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
17. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002, 168:5699-5708.
18. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
19. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
20. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Tan L. The NLRP3 inflammasome in Alzheimer's disease. Mol. Neurobiol. 2013, 48:875-882.
21. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Guan H.S., Tan L. Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals. Neurobiol. Aging 2014, 10.1016/j.neurobiolaging.2014.01.151.
22. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Guan H.S., Tan L. IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice. J. Alzheimers Dis. 2014, 38:633-646.
23. Town T., Vendrame M., Patel A., Poetter D., DelleDonne A., Mori T., et al. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid (1-42). J. Neuroimmunol. 2002, 132:49-59.
24. Townsend K.P., Pratico D. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005, 19:1592-1601.
25. Vom Berg J., Prokop S., Miller K.R., Obst J., Kalin R.E., Lopategui-Cabezas I., et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 2012, 18:1812-1819.
26. Wang L., Liu W., Jiang W., Lin J., Jiang Y., Li B., et al. A miRNA binding site single-nucleotide polymorphism in the 3'-UTR region of the IL23R gene is associated with breast cancer. PLoS One 2012, 7:e49823.
27. Wilson R.S., Barnes L.L., Mendes de Leon C.F., Aggarwal N.T., Schneider J.S., Bach J., et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002, 59:364-370.
28. Xiao Z., Xiao J., Jiang Y., Zhang S., Yu M., Zhao J., et al. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol. Res. 2006, 34:150-155.
29. Yan H., Yuan W., Velculescu V.E., Vogelstein B., Kinzler K.W. Allelic variation in human gene expression. Science 2002, 297:1143.
30. Yang J., Benyamin B., McEvoy B.P., Gordon S., Henders A.K., Nyholt D.R., et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 2010, 42:565-569.
31. Yu J.T., Mou S.M., Wang L.Z., Mao C.X., Tan L. Toll-like receptor 2-196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease. J. Neuroinflammation 2011, 8:136.
32. Yu J.T., Miao D., Cui W.Z., Ou J.R., Tian Y., Wu Z.C., et al. Common variants in toll-like receptor 4 confer susceptibility to Alzheimer's disease in a Han Chinese population. Curr. Alzheimer Res. 2012, 9:458-466.
33. Zwiers A., Kraal L., van de Pouw Kraan T.C., Wurdinger T., Bouma G., Kraal G. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J. Immunol. 2012, 188:1573-1577.